Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients

P Domingo, MK Lamarca… - Journal of …, 2015 - academic.oup.com
Objectives Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-
associated lipodystrophy syndrome (HALS) are common comorbidities in HIV-1-infected …

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients …

P Domingo, MK Lamarca, JM Gallego-Escuredo… - 2015 - cabidigitallibrary.org
Objectives: Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-
associated lipodystrophy syndrome (HALS) are common comorbidities in HIV-1-infected …

[PDF][PDF] Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected …

P Domingo, MK Lamarca… - J Antimicrob …, 2015 - academia.edu
Objectives: Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-
associated lipodystrophy syndrome (HALS) are common comorbidities in HIV-1-infected …

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients

P Domingo, MK Lamarca… - Journal of Antimicrobial …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objectives</jats: title>< jats: p>
Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-associated …

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients …

P Domingo, MK Lamarca… - Journal of …, 2015 - search.ebscohost.com
Objectives: Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-
associated lipodystrophy syndrome (HALS) are common comorbidities in HIV-1-infected …

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients

P Domingo, MK Lamarca… - Journal of …, 2014 - portalrecerca.uab.cat
Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic
disturbances and fat distribution but not cardiovascular risk in HIV-infected patients …

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients

P Domingo, MK Lamarca… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Objectives Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-
associated lipodystrophy syndrome (HALS) are common comorbidities in HIV-1-infected …

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients …

P Domingo, MK Lamarca… - The Journal of …, 2015 - europepmc.org
Objectives Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-
associated lipodystrophy syndrome (HALS) are common comorbidities in HIV-1-infected …

[PDF][PDF] Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected …

P Domingo, MK Lamarca… - J Antimicrob …, 2015 - academia.edu
Objectives: Dyslipidaemia, insulin resistance, metabolic syndrome and HIV/HAART-
associated lipodystrophy syndrome (HALS) are common comorbidities in HIV-1-infected …